Literature DB >> 12666100

Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.

Kevin St P McNaught1, C Warren Olanow.   

Abstract

The etiopathogenesis of Parkinson's disease (PD) has been elusive. Recently, several lines of evidence have converged to suggest that defects in the ubiquitin-proteasome system and proteolytic stress underlie nigral pathology in both familial and sporadic forms of the illness. In support of this concept, mutations in alpha-synuclein that cause the protein to misfold and resist proteasomal degradation cause familial PD. Similarly, mutations in two enzymes involved in the normal function of the ubiquitin-proteasome system, parkin and ubiquitin C-terminal hydrolase L1, are also associated with hereditary PD. Furthermore, structural and function defects in 26/20S proteasomes with accumulation and aggregation of potentially cytotoxic abnormal proteins have been identified in the substantia nigra pars compacta of patients with sporadic PD. Thus, a defect in protein handling appears to be a common factor in sporadic and the various familial forms of PD. This hypothesis may also account for the vulnerability of the substantia nigra pars compacta in PD, why the disorder is age related, and the nature of the Lewy body. It has also facilitated the development of experimental models that recapitulate the behavioral and pathological features of PD, and hopefully will lead to the development of novel neuroprotective therapies for the disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666100     DOI: 10.1002/ana.10512

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  41 in total

Review 1.  Neuroprotection in Parkinson's disease: an elusive goal.

Authors:  William C Koller; Maria G Cersosimo
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

2.  Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicity.

Authors:  Rui Xiong; David Siegel; David Ross
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-22       Impact factor: 4.219

Review 3.  L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease.

Authors:  Norio Ogawa; Masato Asanuma; Ikuko Miyazaki; Francisco J Diaz-Corrales; Ko Miyoshi
Journal:  J Neurol       Date:  2005-10       Impact factor: 4.849

4.  Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells.

Authors:  Hui Yang; Hai-Yan Zhou; Biao Li; Guo-Zhong Niu; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-20       Impact factor: 4.147

5.  Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells.

Authors:  Ichiro Kawahata; Hirofumi Tokuoka; Hasan Parvez; Hiroshi Ichinose
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

6.  Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson's disease.

Authors:  Brian Bauereis; William E Haskins; Richard G Lebaron; Robert Renthal
Journal:  Neurosci Lett       Date:  2010-11-05       Impact factor: 3.046

7.  The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.

Authors:  Michela Campolo; Giovanna Casili; Flavia Biundo; Rosalia Crupi; Marika Cordaro; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Antioxid Redox Signal       Date:  2017-01-27       Impact factor: 8.401

8.  Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults.

Authors:  Fang Liu; Jagadish Hindupur; Jamie L Nguyen; Katie J Ruf; Junyi Zhu; Jeremy L Schieler; Connie C Bonham; Karl V Wood; V Jo Davisson; Jean-Christophe Rochet
Journal:  Free Radic Biol Med       Date:  2008-04-11       Impact factor: 7.376

9.  The activation sequence of cellular protein handling systems after proteasomal inhibition in dopaminergic cells.

Authors:  Rui Xiong; David Siegel; David Ross
Journal:  Chem Biol Interact       Date:  2013-05-14       Impact factor: 5.192

10.  Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKCdelta proteolytic activation and mitochondrial translocation.

Authors:  Faneng Sun; Arthi Kanthasamy; Chunjuan Song; Yongjie Yang; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.